3B-202

N/A

Report date: 2023/01/07 22:56:36
NME

Base Information

Drug Name3B-202
Drug Alias Name3-B-202
ClassificationRadiation-emitting productsSmall molecules > Synthetic peptide
Mechanisms of ActionFibroblast activation protein alpha binders
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbHClovis Oncology Inc
China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbHClovis Oncology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A